Clinical Trial Update: Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of topical imiquimod and a multipeptide vaccine for cutaneous metastases of melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Imiquimod (imiquimod)
• Multipeptide vaccination (multipeptide vaccination)

Snippet

Sponsor: University of Virginia | Conditions: Melanoma | Phase 1 | Status: COMPLETED